Clinical trial
St Mary's Assisted Reproductive Technology and Cardiometabolic Health: Modifiable Targets for Multimorbidity Prevention (START-HEALThY)
NCT07173569 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- St Mary's Assisted Reproductive Technology and Cardiometabolic Health: Modifiable Targets for Multimorbidity Prevention (START-HEALThY)
- Lead sponsor
- University of Manchester
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 1, 2026
- Completion date
- October 31, 2028
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
assisted reproductive technology, cardiovascular health, in vitro fertilisation, infertility, maternal cardiometabolic health, metabolic health